Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testogel endocrine effects study in healthy male athletes
2005-001453-22Phase 3Completed
- Sponsor
- German Sport University Cologne
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of AndroForte, sponsored by German Sport University Cologne. Primary endpoints: Endocrine effects after 9-week treatment/monitoring period, Urinary steroid profiles and 2 more. Started Nov 2005; status: completed.
02
Drugs
AndroForte
Beyond the preview
Go deeper on 2005-001453-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001453-22.